ZA889110B - Method for the treatment of anxiety - Google Patents

Method for the treatment of anxiety

Info

Publication number
ZA889110B
ZA889110B ZA889110A ZA889110A ZA889110B ZA 889110 B ZA889110 B ZA 889110B ZA 889110 A ZA889110 A ZA 889110A ZA 889110 A ZA889110 A ZA 889110A ZA 889110 B ZA889110 B ZA 889110B
Authority
ZA
South Africa
Prior art keywords
anxiety
treatment
Prior art date
Application number
ZA889110A
Other languages
English (en)
Inventor
Francis P Miller
P Miller Francis
Albert A Carr
A Carr Albert
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA889110B publication Critical patent/ZA889110B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA889110A 1987-12-10 1988-12-05 Method for the treatment of anxiety ZA889110B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13116087A 1987-12-10 1987-12-10

Publications (1)

Publication Number Publication Date
ZA889110B true ZA889110B (en) 1989-08-30

Family

ID=22448169

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA889110A ZA889110B (en) 1987-12-10 1988-12-05 Method for the treatment of anxiety

Country Status (6)

Country Link
EP (1) EP0319962A3 (da)
JP (1) JPH02138214A (da)
KR (1) KR890009398A (da)
AU (1) AU608922B2 (da)
DK (1) DK689188A (da)
ZA (1) ZA889110B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093341A (en) * 1987-12-17 1992-03-03 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine derivatives useful as antithrombolytic agents
US5106855A (en) * 1989-12-20 1992-04-21 Merrell Dow Pharmaceuticals Inc. Method for the treatment of glaucoma
DE69105501T2 (de) * 1990-06-01 1995-04-13 Merrell Dow Pharma (+)-alpha-(2,3 dimethoxyphenyl)-1-[2-(fluorophenyl)ethyl]-4-piperidinmethanol.
US6004980A (en) * 1990-06-01 1999-12-21 Merrell Pharmaceuticals, Inc. (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
US5618824A (en) * 1994-03-09 1997-04-08 Merrell Pharmaceuticals Inc. Treatment of obsessive-compulsive disorders with 5-HT2 antagonists
EP0796619A1 (en) * 1996-03-21 1997-09-24 Merrell Pharmaceuticals Inc. Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol in treating depressive disorders and bipolar disorders
US6028083A (en) * 1997-07-25 2000-02-22 Hoechst Marion Roussel, Inc. Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
US6713627B2 (en) 1998-03-13 2004-03-30 Aventis Pharmaceuticals Inc. Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
US6277864B1 (en) 1998-08-28 2001-08-21 Aventis Pharmaceuticals Inc. Use of R- +)-α-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol for the treatment of sleep disorders
US6939879B2 (en) 1998-08-28 2005-09-06 Aventis Pharmaceuticals Inc. Use of R (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of substance induced insomnia
DE102004010132A1 (de) 2004-02-27 2005-09-15 Merck Patent Gmbh Piperidinderivate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1280421C (en) * 1985-07-02 1991-02-19 Albert A. Carr 1,4-disubstituted piperidinyl derivatives
US5093341A (en) * 1987-12-17 1992-03-03 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine derivatives useful as antithrombolytic agents

Also Published As

Publication number Publication date
KR890009398A (ko) 1989-08-01
JPH02138214A (ja) 1990-05-28
DK689188D0 (da) 1988-12-09
DK689188A (da) 1989-06-11
EP0319962A2 (en) 1989-06-14
AU608922B2 (en) 1991-04-18
EP0319962A3 (en) 1990-08-22
AU2659088A (en) 1989-06-15

Similar Documents

Publication Publication Date Title
EP0278745A3 (en) Process for the treatment of waste
EP0311983A3 (en) Method for the preparation of titanium-silicalites
CS253388A2 (en) Method of 10-dihydro-10-dexy-11-azarythronolides prepararation
GB8704089D0 (en) Method of treatment
PH22351A (en) Novel method for the treatment of neoplasms
ZA889110B (en) Method for the treatment of anxiety
ZA887372B (en) Method for the preparation of anilinofumarate
EP0297447A3 (en) Method for the preparation of 2-cyclopentenones
GB8729507D0 (en) Method for phase-synchronisation of step-drive controlled devices
GB2210869B (en) Method and apparatus for the treatment of water
ZA853602B (en) Method for the treatment of neoplasms
GB8916394D0 (en) Method of treatment
BG43729A1 (en) Method for operative treatment of apertognatia
GB8704088D0 (en) Method of treatment
GB8704090D0 (en) Method of treatment
GB8718025D0 (en) Method of treatment
CS274683B2 (en) Method of dialkyldichlorosuccinates
BG44296A1 (en) Method for chemico- thermic treatment
GB8820939D0 (en) Novel method of treatment
BG46628A1 (en) Means for treatment of artrose alterations
CS811987A1 (en) Method of pitches treatment
BG45622A1 (en) Method for prepraing of polyethylentherephthalate
BG43730A1 (en) Surgacal method for treatment of peironi disease
GR3003007T3 (en) Process for the treatment of alpha-calciumsulphate-hemihydrate
GB8618949D0 (en) Method of treatment